We are live on ! Find out more
DA

Dillon & Associates Portfolio holdings

AUM $726M
1-Year Est. Return 18.59%
This Fund
S&P 500
This Quarter Est. Return
-5.08%
1 Year Est. Return
+18.59%
3 Year Est. Return
+92.03%
5 Year Est. Return
+130.73%
10 Year Est. Return
+511.58%
AUM
$726M
AUM Growth
-$48M
Cap. Flow
+$1.93M
Cap. Flow %
0.27%
Top 10 Hldgs %
60.16%
Holding
79
New
2
Increased
31
Reduced
33
Closed
4

Top Buys

Rank Stock Value
1
NFLX icon
Netflix
NFLX
+$3M
2
CASY icon
Casey's General Stores
CASY
+$2.34M
3
LLY icon
Eli Lilly
LLY
+$1.87M
4
PANW icon
Palo Alto Networks
PANW
+$1.54M
5
ISRG icon
Intuitive Surgical
ISRG
+$1.22M

Top Sells

Rank Stock Value
1
NVO
Novo Nordisk
NVO
+$4.49M
2
NVDA icon
NVIDIA
NVDA
+$2.13M
3
FISV
Fiserv Inc
FISV
+$1.48M
4
PEP icon
PepsiCo
PEP
+$1.43M
5
PAYX icon
Paychex
PAYX
+$828K

Sector Composition

Rank Sector Weight
1 Technology 38.45%
2 Healthcare 15.1%
3 Consumer Discretionary 13.77%
4 Communication Services 11.5%
5 Financials 5.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AMGN icon
51
Amgen
AMGN
$208B
$883K 0.12%
2,508
+25
+1% +$8.91K
SYY icon
52
Sysco
SYY
$40.8B
$853K 0.12%
12,014
-1,491
-11% -$123K
QCOM icon
53
Qualcomm
QCOM
$155B
$818K 0.11%
6,342
+9
+0.1% +$1.31K
AXP icon
54
American Express
AXP
$227B
$492K 0.07%
+1,629
New +$546K
ROK icon
55
Rockwell Automation
ROK
$53.4B
$472K 0.07%
1,315
+128
+11% +$50.5K
HSY icon
56
Hershey
HSY
$35.2B
$443K 0.06%
2,128
-330
-13% -$69.6K
CSCO icon
57
Cisco
CSCO
$457B
$422K 0.06%
5,413
– –
EMR icon
58
Emerson Electric
EMR
$83.9B
$420K 0.06%
3,208
– –
TSM icon
59
TSMC
TSM
$2.1T
$380K 0.05%
1,125
+125
+13% +$43K
AFL icon
60
Aflac
AFL
$64.9B
$363K 0.05%
3,300
– –
GEV icon
61
GE Vernova
GEV
$264B
$360K 0.05%
+412
New +$321K
DIS icon
62
Walt Disney
DIS
$167B
$328K 0.05%
3,420
-1,520
-31% -$161K
TSLA icon
63
Tesla
TSLA
$1.23T
$322K 0.04%
865
– –
MRSH
64
Marsh
MRSH
$90.5B
$311K 0.04%
1,800
– –
NVS icon
65
Novartis
NVS
$297B
$311K 0.04%
2,031
-171
-8% -$26.2K
MDLZ icon
66
Mondelez International
MDLZ
$79.5B
$310K 0.04%
5,347
-3,228
-38% -$187K
UNH icon
67
UnitedHealth
UNH
$376B
$302K 0.04%
1,113
– –
ENB icon
68
Enbridge
ENB
$119B
$283K 0.04%
5,237
– –
KO icon
69
Coca-Cola
KO
$377B
$283K 0.04%
3,727
+2
+0.1% +$151
COF icon
70
Capital One
COF
$128B
$273K 0.04%
1,502
– –
USB icon
71
US Bancorp
USB
$98.2B
$269K 0.04%
5,176
– –
LIN icon
72
Linde
LIN
$221B
$253K 0.03%
511
+3
+0.6% +$1.42K
BRK.B icon
73
Berkshire Hathaway Class B
BRK.B
$1.1T
$247K 0.03%
515
-5
-1% -$2.45K
ADBE icon
74
Adobe
ADBE
$99.5B
$224K 0.03%
923
-493
-35% -$137K
IBRX icon
75
ImmunityBio
IBRX
$7.51B
$190K 0.03%
23,800
-2,000
-8% -$13.7K
1 2
3
4

Similar funds

TC
Torno Capital Cohasset, Massachusetts $725M AUM 62.71% 1-Year Est. Return
F
FIFTHDELTA London, United Kingdom $725M AUM 11.7% 1-Year Est. Return
SDH
Sloy Dahl & Holst Vancouver, Washington $728M AUM 37.66% 1-Year Est. Return
SCM
SKBA Capital Management San Francisco, California $728M AUM 12.18% 1-Year Est. Return
MWP
Meridian Wealth Partners Exton, Pennsylvania $729M AUM 15.61% 1-Year Est. Return
FAN
Financial Advisors Network Tustin, California $724M AUM 14.91% 1-Year Est. Return
TFHU
TLT Family Holdco ULC Toronto $724M AUM 24.23% 1-Year Est. Return
AGAM
Avalon Global Asset Management San Francisco, California $724M AUM 52.97% 1-Year Est. Return

Dillon & Associates's Q1 2026 Portfolio in Review

As of Q1 2026, Dillon & Associates held 79 positions worth $726M, down 6.2% from $774M the previous quarter. Its ten largest holdings account for 60% of the portfolio.

Dillon & Associates's Q1 2026 filing shows 2 new, 31 increased, 33 reduced and 4 closed positions. Its largest new stake was American Express: 1,629 shares worth $492K. The largest sale was Novo Nordisk, an estimated $4.49M.

By sector, the portfolio is most concentrated in Technology at 38% of assets, down from 40% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Dillon & Associates's largest Q1 2026 buy was American Express: 1,629 shares worth $492K.
  • Dillon & Associates added most to Netflix in Q1 2026, an estimated $3M increase.
  • Dillon & Associates's biggest Q1 2026 reduction was Novo Nordisk, cutting an estimated $4.49M.
  • Dillon & Associates fully exited Fiserv Inc in Q1 2026, selling an estimated $1.48M.
  • Dillon & Associates's ten largest holdings make up 60% of its $726M portfolio in Q1 2026.
  • Dillon & Associates opened 2 new positions and closed 4 in Q1 2026.
  • Dillon & Associates's portfolio value fell 6.2% quarter-over-quarter to $726M.

Based on Dillon & Associates's 13F filing for Q1 2026, filed 7 May 2026.